glaucoma

New approaches and technologies offer hope in vision restorationNew agents and devices offer promise to control IOP and slow, perhaps even stop, the advancing vision loss that is common in glaucoma. Research and development to restore vision is starting to show significant results in preclinical models and early stage clinical trials.
Addressing ocular surface toxicity in glaucoma patientsDry eye is common in patients with glaucoma and often presumed to be related to the preservative in IOP-lowering medications. Considering alternate causes should also be weighed, in addition to a variety of management techniques.
New technology helps IOP measurementNot long ago, a colleague asked me if I performed Goldmann tonometry on all of my glaucoma patients. Without hesitation I said, “No.” When asked why not, I simply answered that not all of my patients are physically able to have the test performed on them.
Flying Eye Hospital aims to prevent blindness worldwide
Flying Eye Hospital aims to prevent blindness worldwideA unique, third-generation Flying Eye Hospital is giving wings to Orbis' mission to prevent blindness worldwide. The hospital is the world’s only mobile ophthalmic teaching hospital located on an MD-10 aircraft, and is the byproduct of six years of work by experts in aviation and hospital engineering.
6 things you need to know: Genetic markers for glaucoma identifiedThe latest news and research you need to know about this week.
Novel dual agonist leads to notable IOP loweringThe drug ONO-9054 led to a greater reduction in IOP and a longer duration of reduction in a small clinical trial compared with latanoprost.
Lab RGCs expanding opportunities for glaucoma researchRetinal ganglion cells can be generated from patient-specific, induced pluripotent stem cells and serve as an in vitro model for pharmacologic screening and pathophysiology studies.
What astronauts can teach us about glaucoma
What astronauts can teach us about glaucomaNASA’s Vision Impairment and Intracranial Pressure (VIIP) project was started after NASA realized many astronauts return from space with vision problems, and these problems may last for years after mission completion.
How alcohol consumption correlates with glaucoma
How alcohol consumption correlates with glaucomaWith the advent of electronic health records, it is now easier than ever to keep up with what medications a patient is actually taking, and (especially in the arena of glaucoma) the several classes of medications, such as steroids, beta blockers, and antihistamines, that can influence how patients’ eyes behave. With this in mind, I had a patient come in the other day with an interesting question regarding her intraocular pressure (IOP).
8 things you missed at ARVO and ACSRS 2016It’s been a busy week for ophthalmology research and news after both the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle and the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in New Orleans.